bpc-157 fda warning august 2025 On 15 2025, the U.S. Food & Drug Administration (FDA) issued a Letter to Platinum Biologics LLC for marketing umbilical‑cord‑derived products including exosome products (“NanoEx” & “Nano Xsomes”) without approval RFK Jr pushes for FDA
RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn bpc 157 not approved for human use fda warning fda warning bpc 157 unapproved peptide safety risk bpc 157 fda warning not approved FDA Compliance for Peptide Therapy and BPC 157 Holt Law covingtoncountyhospital FDA panel to review popular peptides amid persistent consumer appetite The Journal Record The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means Pharmacy Times FDA's Overreach on Compounded Peptides
Pay in 4 interest-free payments of $6.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



